Use access key #2 to skip to page content.
$0.29 -0.03 (-9.38%)
10/10/2008 4:00 PM

Generex Biotechnology Corp (GNBT)

CAPS Rating:
***

The Company is engaged primarily in the research, development and commercialization of drug delivery systems and technologies.

View All Commentary (GNBT)

Recs

0

Avatar edjab (< 20) Submitted: 1/02/08 9:37 AM : Outperform Start Price: $1.65 GNBT Score: -42.73

Good potential. desired remedy. easy medication control for diabetes & others.

Report this Post Replies: 0 | Reply

Featured Broker Partners